These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice. Li BH; Jiang W; Zhang S; Huang N; Sun J; Yang J; Li ZF Mol Immunol; 2020 Sep; 125():95-103. PubMed ID: 32659598 [TBL] [Abstract][Full Text] [Related]
4. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events. Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002 [TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice. Schmid M; Zimara N; Wege AK; Ritter U Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017 [TBL] [Abstract][Full Text] [Related]
6. Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis. Wang W; Jiao Z; Duan T; Liu M; Zhu B; Zhang Y; Xu Q; Wang R; Xiong Y; Xu H; Lu L Eur J Immunol; 2015 Feb; 45(2):464-73. PubMed ID: 25352399 [TBL] [Abstract][Full Text] [Related]
7. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model. Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155 [TBL] [Abstract][Full Text] [Related]
8. CCR5 Directs the Mobilization of CD11b Hawila E; Razon H; Wildbaum G; Blattner C; Sapir Y; Shaked Y; Umansky V; Karin N Cell Rep; 2017 Nov; 21(8):2212-2222. PubMed ID: 29166611 [TBL] [Abstract][Full Text] [Related]
9. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs. Tannenbaum CS; Rayman PA; Pavicic PG; Kim JS; Wei W; Polefko A; Wallace W; Rini BI; Morris-Stiff G; Allende DS; Hamilton T; Finke JH; Diaz-Montero CM Cancer Immunol Res; 2019 Oct; 7(10):1687-1699. PubMed ID: 31439615 [TBL] [Abstract][Full Text] [Related]
11. The Voltage-Gated Hv1 H Cozzolino M; Gyöngyösi A; Korpos E; Gogolak P; Naseem MU; Kállai J; Lanyi A; Panyi G Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047188 [TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624 [TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of myeloid-derived suppressor cells-associated chemokine MIP-1γ and its receptor CCR1 in the spleen of hepatoma H22-bearing mice]. Li B; Chen H; Shi M; Huang N; Kong G; Li Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):802-808. PubMed ID: 32967764 [TBL] [Abstract][Full Text] [Related]
14. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs. Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024 [TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer. Takeyama Y; Kato M; Tamada S; Azuma Y; Shimizu Y; Iguchi T; Yamasaki T; Gi M; Wanibuchi H; Nakatani T Cancer Lett; 2020 Jun; 479():89-99. PubMed ID: 32200039 [TBL] [Abstract][Full Text] [Related]
16. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative. Karin N Front Immunol; 2020; 11():557586. PubMed ID: 33193327 [TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cell function is diminished in aspirin-triggered allergic airway hyperresponsiveness in mice. Shi M; Shi G; Tang J; Kong D; Bao Y; Xiao B; Zuo C; Wang T; Wang Q; Shen Y; Wang H; Funk CD; Zhou J; Yu Y J Allergy Clin Immunol; 2014 Nov; 134(5):1163-74.e16. PubMed ID: 24948368 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma. Han KQ; He XQ; Ma MY; Guo XD; Zhang XM; Chen J; Han H; Zhang WW; Zhu QG; Nian H; Ma LJ World J Gastroenterol; 2015 Apr; 21(16):4864-74. PubMed ID: 25944999 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26. Chiu DK; Xu IM; Lai RK; Tse AP; Wei LL; Koh HY; Li LL; Lee D; Lo RC; Wong CM; Ng IO; Wong CC Hepatology; 2016 Sep; 64(3):797-813. PubMed ID: 27228567 [TBL] [Abstract][Full Text] [Related]
20. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2 Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK Front Immunol; 2022; 13():993444. PubMed ID: 36685592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]